Sign in

CIK 0001232524 · Large accelerated filer

Jazz Pharmaceuticals plc

Sign in to watch
Ticker
JAZZ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
operating
EIN
981032470
Phone
353-1-634-7800
Business address
FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
Former names
JAZZ PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,420,682
in 10 filings, $24.9M under 10b5-1 plans

Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-05 Iannone Robert EVP, Global Head of Research a Shares withheld for taxes −2,274 $142.78 $325K 46,489
2023-03-05 Carr Patricia SVP, Chief Accounting Officer Sale −1,148 $140.76 $162K 7,309
2023-03-05 GALA RENEE D EVP & Chief Financial Officer Shares withheld for taxes −1,557 $142.78 $222K 43,785
2023-03-05 Patil Neena M EVP & Chief Legal Officer Shares withheld for taxes −1,923 $142.78 $275K 34,339
2023-03-05 Pearce Samantha SVP, Head of Europe & Internat Shares withheld for taxes −2,020 $142.78 $288K 13,159
2023-03-05 Sablich Kim EVP, GM of U.S., Commercial Ma Shares withheld for taxes −1,610 $142.78 $230K 33,573
2023-03-05 COZADD BRUCE C Chairman & CEO Shares withheld for taxes −21,882 $142.78 $3.1M 387,584
2023-03-04 Mulligan Seamus Director Option exercise +4,500 $59.13 $266K 1,164,800
2023-03-04 Mulligan Seamus Director Option exercise · Non-Qualified Stock Option (right to buy) −4,500 0
2023-03-03 Larkin Finbar SVP, Technical Operations Grant or award +4,373 23,854
2023-03-03 Swisher Daniel N JR President and COO Grant or award +13,456 60,440
2023-03-03 Iannone Robert EVP, Global Head of Research a Grant or award +12,447 48,763
2023-03-03 Carr Patricia SVP, Chief Accounting Officer Grant or award +2,523 8,457
2023-03-03 GALA RENEE D EVP & Chief Financial Officer Grant or award +12,784 45,342
2023-03-03 Patil Neena M EVP & Chief Legal Officer Grant or award +9,419 36,262
2023-03-03 Pearce Samantha SVP, Head of Europe & Internat Grant or award +3,870 15,179
2023-03-03 Sablich Kim EVP, GM of U.S., Commercial Ma Grant or award +10,429 35,183
2023-03-03 COZADD BRUCE C Chairman & CEO Grant or award +42,388 409,466
2023-02-02 Pearce Samantha SVP, Head of Europe & Internat Option exercise +531 $109.45 $58K 11,840
2023-02-02 Pearce Samantha SVP, Head of Europe & Internat Sale −531 $157.26 $84K 11,309

Page 20 of 31 · 614 trades